Design and synthesis of new potent N,N -bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents-Reference-Cited by-同舟云学术

Design and synthesis of new potent N,N -bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents

Published:2018-03 Issue: Volume:147 Page:7-20
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Dei Silvia,Coronnello Marcella,Bartolucci Gianluca,Manetti Dina^ORCID,Romanelli Maria Novella,Udomtanakunchai Chatchanok,Salerno Milena,Teodori Elisabetta^ORCID

Funder

MIUR

University of Florence

CMU Short Term Research Fellowships in Overseas

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference45 articles.

1. Multiple drug resistance;Mitcher;Med. Res. Rev.,1999

2. Active efflux across the blood-brain barrier: role of the solute carrier family;Kusuhara;NeuroRx,2005

3. Transporters and drug therapy: implications for drug disposition and disease;Ho;Clin. Pharmacol. Ther.,2005

4. Genetics of multidrug resistance: relationship of a cloned gene to the complete multidrug resistant phenotype;Croop;Canc. Res.,1987

5. Isolation and expression of a complementary DNA that confers multidrug resistance;Gros;Nature,1986

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold;Molecules;2024-07-11

2. Axial Phenoxylation of Aluminum Phthalocyanines for Improved Cannabinoid Sensitivity in OTFT Sensors;Advanced Science;2024-04-19

3. Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein;Scientific Reports;2024-01-02

4. Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review);International Journal of Oncology;2023-08-28

5. Synthesis and molecular-based analysis of betulin derivatives as strong multidrug reversal agents targeting P-glycoprotein;2023-05-24